P Clark1,2, E Denova-Gutiérrez3, C Razo4, M J Rios-Blancas4, R Lozano4,5. 1. Clinical Epidemiology Research Unit, Hospital Infantil de México Federico Gómez, Mexico City, Mexico. 2. School of Medicine, Universidad Nacional Autónoma de México, Mexico City, Mexico. 3. Nutrition and Health Research Center, National Institute of Public Health, 655 Colonia Santa María Ahuacatitlán, C.P, 62100, Cuernavaca, Mexico. edgar.denova@insp.mx. 4. National Institute of Public Health, Cuernavaca, Mexico. 5. Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Abstract
Worldwide, musculoskeletal (MSK) disorders are the second cause of living with disability. According to our data, in Mexico, MSK conditions are an important cause of disability, at national and state level. Preventive actions promoted by health systems to reduce the burden of MSK disorders are essential. INTRODUCTION: We describe premature mortality and disability due to musculoskeletal (MSK) disorders in Mexico at national and state level from 1990 to 2016. METHODS: Using data from the global burden of disease study 2016 (GBD 2016), we present rates and trends in years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life years (DALYs) caused by MSK disorders in Mexico by state from 1990 to 2016. The burden of MSK disorders was computed using standard GBD methodology. To compare the burden of MSK disorders across the country, states were grouped by sociodemographic index (SDI). RESULTS: In Mexico, MSK disorders were the 3rd and 17th greatest cause of YLDs and YLLs in 2016, respectively, accounting for 1.95 million (95% UI 1.4-2.5) DALYs. Among all MSK disorders, low back and neck pain had the highest all-ages DALYs rate and represented 3.6% of total DALYs. All-ages YLLs and YLDs rates of MSK disorders were 234 and 37% higher in females (YLLs 102.2, 95% UI 79.9-110.7; YLDs 1677.9, 95% UI 1213.5-2209.4) than in males (YLLs 30.6, 95% UI 28.3-34.0; YLDs 1224.7, 95% UI 887.2-1608.3), respectively. Northern and high SDI states had higher rates of MSK disorders in comparison with southern and low SDI states. Only 16% of YLDs caused by all MSK disorders could be attributed to risk factors currently assessed in GBD. CONCLUSION: MSK conditions are an important cause of premature mortality and disability. Researcher engagement and cross-sectorial actions to address the burden of MSK disorders are essential.
Worldwide, musculoskeletal (MSK) disorders are the second cause of living with disability. According to our data, in Mexico, MSK conditions are an important cause of disability, at national and state level. Preventive actions promoted by health systems to reduce the burden of MSK disorders are essential. INTRODUCTION: We describe premature mortality and disability due to musculoskeletal (MSK) disorders in Mexico at national and state level from 1990 to 2016. METHODS: Using data from the global burden of disease study 2016 (GBD 2016), we present rates and trends in years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life years (DALYs) caused by MSK disorders in Mexico by state from 1990 to 2016. The burden of MSK disorders was computed using standard GBD methodology. To compare the burden of MSK disorders across the country, states were grouped by sociodemographic index (SDI). RESULTS: In Mexico, MSK disorders were the 3rd and 17th greatest cause of YLDs and YLLs in 2016, respectively, accounting for 1.95 million (95% UI 1.4-2.5) DALYs. Among all MSK disorders, low back and neck pain had the highest all-ages DALYs rate and represented 3.6% of total DALYs. All-ages YLLs and YLDs rates of MSK disorders were 234 and 37% higher in females (YLLs 102.2, 95% UI 79.9-110.7; YLDs 1677.9, 95% UI 1213.5-2209.4) than in males (YLLs 30.6, 95% UI 28.3-34.0; YLDs 1224.7, 95% UI 887.2-1608.3), respectively. Northern and high SDI states had higher rates of MSK disorders in comparison with southern and low SDI states. Only 16% of YLDs caused by all MSK disorders could be attributed to risk factors currently assessed in GBD. CONCLUSION: MSK conditions are an important cause of premature mortality and disability. Researcher engagement and cross-sectorial actions to address the burden of MSK disorders are essential.
Entities:
Keywords:
DALYs; Global burden of disease 2016; Mexico; Musculoskeletal disorders
Authors: Ingris Peláez-Ballestas; Luz Helena Sanin; José Moreno-Montoya; José Alvarez-Nemegyei; Rubén Burgos-Vargas; Mario Garza-Elizondo; Jacqueline Rodríguez-Amado; Maria-Victoria Goycochea-Robles; Marco Madariaga; Jorge Zamudio; Natalia Santana; Mario H Cardiel Journal: J Rheumatol Suppl Date: 2011-01
Authors: Héctor Gómez-Dantés; Héctor Lamadrid-Figueroa; Lucero Cahuana-Hurtado; Omar Silverman-Retana; Pablo Montero; María Cecilia González-Robledo; Christina Fitzmaurice; Amanda Pain; Christine Allen; Daniel J Dicker; Hannah Hamavid; Alan López; Christopher Murray; Mohsen Naghavi; Rafael Lozano Journal: Salud Publica Mex Date: 2016-04
Authors: Héctor Gómez-Dantés; Nancy Fullman; Héctor Lamadrid-Figueroa; Lucero Cahuana-Hurtado; Blair Darney; Leticia Avila-Burgos; Ricardo Correa-Rotter; Juan A Rivera; Simon Barquera; Eduardo González-Pier; Tania Aburto-Soto; Elga Filipa Amorin de Castro; Tonatiuh Barrientos-Gutiérrez; Ana C Basto-Abreu; Carolina Batis; Guilherme Borges; Ismael Campos-Nonato; Julio C Campuzano-Rincón; Alejandra de Jesús Cantoral-Preciado; Alejandra G Contreras-Manzano; Lucia Cuevas-Nasu; Vanessa V de la Cruz-Gongora; Jose L Diaz-Ortega; María de Lourdes García-García; Armando Garcia-Guerra; Teresita González de Cossío; Luz D González-Castell; Ileana Heredia-Pi; Marta C Hijar-Medina; Alejandra Jauregui; Aida Jimenez-Corona; Nancy Lopez-Olmedo; Carlos Magis-Rodríguez; Catalina Medina-Garcia; Maria E Medina-Mora; Fabiola Mejia-Rodriguez; Julio C Montañez; Pablo Montero; Alejandra Montoya; Grea L Moreno-Banda; Andrea Pedroza-Tobías; Rogelio Pérez-Padilla; Amado D Quezada; Vesta L Richardson-López-Collada; Horacio Riojas-Rodríguez; Maria J Ríos Blancas; Christian Razo-Garcia; Martha P Romero Mendoza; Tania G Sánchez-Pimienta; Luz M Sánchez-Romero; Astrid Schilmann; Edson Servan-Mori; Teresa Shamah-Levy; Martha M Téllez-Rojo; José L Texcalac-Sangrador; Haidong Wang; Theo Vos; Mohammad H Forouzanfar; Mohsen Naghavi; Alan D Lopez; Christopher J L Murray; Rafael Lozano Journal: Lancet Date: 2016-10-05 Impact factor: 79.321
Authors: Lyn March; Emma U R Smith; Damian G Hoy; Marita J Cross; Lidia Sanchez-Riera; Fiona Blyth; Rachelle Buchbinder; Theo Vos; Anthony D Woolf Journal: Best Pract Res Clin Rheumatol Date: 2014-11-18 Impact factor: 4.098
Authors: Andrew M Briggs; Anthony D Woolf; Karsten Dreinhöfer; Nicole Homb; Damian G Hoy; Deborah Kopansky-Giles; Kristina Åkesson; Lyn March Journal: Bull World Health Organ Date: 2018-04-12 Impact factor: 9.408
Authors: Alfonso Gastelum Strozzi; Ingris Peláez-Ballestas; Ysabel Granados; Rubén Burgos-Vargas; Rosana Quintana; John Londoño; Sergio Guevara; Oscar Vega-Hinojosa; José Alvarez-Nemegyei; Vicente Juarez; César Pacheco-Tena; Ligia Cedeño; Mario Garza-Elizondo; Ana María Santos; María Victoria Goycochea-Robles; Astrid Feicán; Hazel García; Flor Julian-Santiago; María Elena Crespo; Jacqueline Rodriguez-Amado; Juan Camilo Rueda; Adriana Silvestre; Jorge Esquivel-Valerio; Celenia Rosillo; Susana Gonzalez-Chavez; Everardo Alvarez-Hernández; Adalberto Loyola-Sanchez; Eduardo Navarro-Zarza; Marco Maradiaga; Julio Casasola-Vargas; Natalia Sanatana; Imelda Garcia-Olivera; Mario Goñi; Luz Helena Sanin; Rocío Gamboa; Mario Humberto Cardiel; Bernardo A Pons-Estel Journal: Clin Rheumatol Date: 2020-03-30 Impact factor: 2.980
Authors: Maria M Johansson; Marco Barbero; Anneli Peolsson; Deborah Falla; Corrado Cescon; Anna Folli; Huan-Ji Dong Journal: Int J Environ Res Public Health Date: 2021-01-22 Impact factor: 3.390
Authors: Katie de Luca; Andrew M Briggs; Simon D French; Manuela L Ferreira; Marita Cross; Fiona Blyth; Lyn March Journal: Chiropr Man Therap Date: 2022-05-03